
Uzimet GP 1mg/500mg/15mg Tablet SR
Marketer
Dr Kumars Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Uzimet GP 1mg/500mg/15mg Tablet SR
Glycemic control in adults with type 2 diabetes mellitus is facilitated by the combined action of the components in the extended-release Uzimet GP 1mg/500mg/15mg tablet. This medication, used alongside a balanced diet and regular exercise, enhances insulin efficiency, resulting in reduced blood glucose levels. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in such cases, omit the missed dose and resume the regular schedule. Never double the dose to compensate. Excessive intake may cause dangerously low blood sugar (hypoglycemia). Concomitant use with other antidiabetic agents, alcohol consumption, or skipped meals increases the hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects can include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing therapy, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function will be assessed by your doctor before initiating treatment. Limit alcohol consumption to mitigate the potential for amplified side effects.
Primary Ingredients of Uzimet GP 1mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Uzimet GP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Uzimet GP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Uzimet GP 1mg/500mg/15mg SR tablets with a meal.
Common Side effects of Uzimet GP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Uzimet GP 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Uzimet GP 1mg/500mg/15mg Extended-Release Tablets with food.
How Uzimet GP 1mg/500mg/15mg Tablet SR works:
Uzimet GP 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Uzimet GP 1mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Uzimet GP 1mg/500mg/15mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before recommending this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Uzimet GP tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Uzimet GP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated for those with severe kidney disease. Routine kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Uzimet GP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is necessary. The use of Uzimet GP 1mg/500mg/15mg Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Uzimet GP 1mg/500mg/15mg Tablet SR :
Should you forget to take a Uzimet GP 1mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Uzimet GP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
